End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.9 CNY | -0.27% | -2.42% | -2.42% |
Feb. 20 | Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection | MT |
Feb. 20 | Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation | MT |
Sales 2021 | 36.23B 5B | Sales 2022 | 37.59B 5.19B | Capitalization | 25.77B 3.56B |
---|---|---|---|---|---|
Net income 2021 | 647M 89.29M | Net income 2022 | 736M 102M | EV / Sales 2021 | 0.4 x |
Net Debt 2021 | 1.88B 259M | Net Debt 2022 | 1.09B 150M | EV / Sales 2022 | 0.71 x |
P/E ratio 2021 |
19.5
x | P/E ratio 2022 |
35
x | Employees | 8,313 |
Yield 2021 |
1.54% | Yield 2022 |
0.86% | Free-Float | 44.6% |
1 day | -0.27% | ||
1 week | -2.42% | ||
Current month | -1.00% | ||
1 month | -0.55% | ||
3 months | -2.68% | ||
6 months | -4.89% | ||
Current year | -2.42% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Dong Hu
CEO | Chief Executive Officer | 48 | 21-09-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Min Zhang
BRD | Director/Board Member | 62 | 22-08-17 |
Yong Qiang
CHM | Chairman | 58 | 09-09-14 |
Shao Feng Zhang
BRD | Director/Board Member | 46 | Dec. 20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 2 M€ | -18.13% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 10.9 | -0.27% | 7,771,089 |
24-04-24 | 10.93 | +0.55% | 9,503,658 |
24-04-23 | 10.87 | -1.27% | 10,942,310 |
24-04-22 | 11.01 | -1.52% | 14,716,340 |
24-04-19 | 11.18 | +0.09% | 13,895,680 |
End-of-day quote Shanghai S.E., April 24, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-2.42% | 2.25B | |
+16.62% | 70.95B | |
+2.99% | 25.25B | |
+5.38% | 8.67B | |
+6.46% | 8.16B | |
-21.01% | 7.91B | |
+0.06% | 4.51B | |
+17.12% | 4.31B | |
-0.14% | 4.07B | |
-3.57% | 3.84B |
- Stock Market
- Equities
- 600056 Stock